Literature DB >> 10749009

Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample.

K A Donovan1, D C Tucker.   

Abstract

Informed consent for genetic testing for breast-ovarian cancer susceptibility requires that women understand basic concepts about the inheritance of cancer susceptibility and the benefits and risks associated with genetic testing. Women awaiting routine medical services (N = 220) were surveyed about their knowledge of breast cancer and cancer genetics and their perceptions of genetic testing and personal risk. There were no racial differences in median income or mean level of education. Compared to Caucasian women, African American women knew significantly less about breast cancer and about genetic risk for breast cancer. African American women had different psychological, social, and economic concerns as evidenced by how they weighted the benefits and risks of genetic testing. This study is the first to assess several dimensions of informed consent for genetic testing among a sociodemographically diverse group. The findings should enable health professionals to target the African American and lower-income populations with the appropriate education and counseling.

Entities:  

Mesh:

Year:  2000        PMID: 10749009     DOI: 10.1023/a:1005416203239

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  31 in total

1.  Testing for inherited susceptibility to breast cancer: a survey of informed consent forms for BRCA1 and BRCA2 mutation testing.

Authors:  S J Durfy; T E Buchanan; W Burke
Journal:  Am J Med Genet       Date:  1998-01-06

Review 2.  The "epidemic" of breast cancer in the U.S.--determining the factors.

Authors:  S E King; D Schottenfeld
Journal:  Oncology (Williston Park)       Date:  1996-04       Impact factor: 2.990

3.  Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.

Authors: 
Journal:  J Clin Oncol       Date:  1996-05       Impact factor: 44.544

Review 4.  Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent.

Authors:  G Geller; J R Botkin; M J Green; N Press; B B Biesecker; B Wilfond; G Grana; M B Daly; K Schneider; M J Kahn
Journal:  JAMA       Date:  1997-05-14       Impact factor: 56.272

Review 5.  Risk factors.

Authors:  D J Marchant
Journal:  Obstet Gynecol Clin North Am       Date:  1994-12       Impact factor: 2.844

Review 6.  Genetic testing: employability, insurability, and health reform.

Authors:  M A Rothstein
Journal:  J Natl Cancer Inst Monogr       Date:  1995

7.  Assessment and counseling for women with a family history of breast cancer. A guide for clinicians.

Authors:  K F Hoskins; J E Stopfer; K A Calzone; S D Merajver; T R Rebbeck; J E Garber; B L Weber
Journal:  JAMA       Date:  1995-02-15       Impact factor: 56.272

8.  Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Authors:  C Lerman; B Biesecker; J L Benkendorf; J Kerner; A Gomez-Caminero; C Hughes; M M Reed
Journal:  J Natl Cancer Inst       Date:  1997-01-15       Impact factor: 13.506

Review 9.  Predictive genetic tests: problems and pitfalls.

Authors:  J G Davis
Journal:  Ann N Y Acad Sci       Date:  1997-12-29       Impact factor: 5.691

10.  Women's receptivity to testing for a genetic susceptibility to breast cancer.

Authors:  H Chaliki; S Loader; J C Levenkron; W Logan-Young; W J Hall; P T Rowley
Journal:  Am J Public Health       Date:  1995-08       Impact factor: 9.308

View more
  44 in total

1.  Perceived risk for breast cancer and its relationship to mammography in Blacks, Hispanics, and Whites.

Authors:  Heather Orom; Marc T Kiviniemi; Vickie L Shavers; Levi Ross; Willie Underwood
Journal:  J Behav Med       Date:  2012-07-08

Review 2.  Communicating genetic risk information for common disorders in the era of genomic medicine.

Authors:  Denise M Lautenbach; Kurt D Christensen; Jeffrey A Sparks; Robert C Green
Journal:  Annu Rev Genomics Hum Genet       Date:  2013       Impact factor: 8.929

Review 3.  Cancers related to genetic mutations: important psychosocial issues for Canadian family physicians.

Authors:  Tara E Power; John Robinson
Journal:  Can Fam Physician       Date:  2006-11       Impact factor: 3.275

4.  Community engagement about genetic variation research.

Authors:  Sharon F Terry; Kurt D Christensen; Susan Metosky; Gayle Rudofsky; Kathleen P Deignan; Hulda Martinez; Penelope Johnson-Moore; Toby Citrin
Journal:  Popul Health Manag       Date:  2011-08-04       Impact factor: 2.459

5.  Challenges to recruitment and retention of African Americans in the gene-environment trial of response to dietary interventions (GET READI) for heart health.

Authors:  Betty M Kennedy; David W Harsha; Ebony B Bookman; Yolanda R Hill; Tuomo Rankinen; Ruben Q Rodarte; Connie D Murla
Journal:  Health Educ Res       Date:  2011-08-23

6.  Factors associated with an individuals' decision to withdraw from genetic counseling for BRCA1 and BRCA2 genes mutations: are personality traits involved?

Authors:  Anita Caruso; Cristina Vigna; Valentina Bigazzi; Carlo Leone; Gabriella Maggi; Aline Martayan; Fabio M Sega; Francesco Cognetti; Antonella Savarese
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

7.  Factors associated with willingness to provide biospecimens for genetics research among African American cancer survivors.

Authors:  Altovise T Ewing; Nnenna Kalu; Gloria Cain; Lori H Erby; Luisel J Ricks-Santi; Eva Tetteyfio-Kidd Telemaque; Denise M Scott
Journal:  J Community Genet       Date:  2019-03-14

8.  The Role of Knowledge on Genetic Counseling and Testing in Black Cancer Survivors at Increased Risk of Carrying a BRCA1/2 Mutation.

Authors:  Alejandra Hurtado-de-Mendoza; Monica C Jackson; Lyndsay Anderson; Vanessa B Sheppard
Journal:  J Genet Couns       Date:  2016-07-12       Impact factor: 2.537

9.  "Why take it if you don't have anything?" breast cancer risk perceptions and prevention choices at a public hospital.

Authors:  Talya Salant; Pamela S Ganschow; Olufunmilayo I Olopade; Diane S Lauderdale
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

10.  The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample.

Authors:  Anita Caruso; Cristina Vigna; Gabriella Maggi; Fabio Massimo Sega; Francesco Cognetti; Antonella Savarese
Journal:  J Exp Clin Cancer Res       Date:  2008-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.